Curium to market xenon-133 gas in the U.S.

Global nuclear medicine firm Curium has expanded its U.S. offerings to include xenon-133 gas, sourced from its Petten manufacturing facility in the Netherlands and using low-enriched uranium targets.

Xenon-133 gas is useful for diagnostic inhalation studies to evaluate pulmonary function and for lung imaging, and it may also be used to assess cerebral blood flow, the company said.

Page 1 of 1235
Next Page